Hanover Bancorp director gets 1,592-share stock grant

Hanover Bancorp, Inc. director Philip A. Okun reported receiving a grant of 1,592 shares of common stock on February 5, 2026.

Rhea-AI Filing Summary

Hanover Bancorp, Inc. director Philip A. Okun reported receiving a grant of 1,592 shares of common stock on February 5, 2026. The shares are restricted stock awarded at a price of $0.0000 per share and are subject to forfeiture.

The grant vests over three years, with one-third of the shares vesting on each of March 1, 2027, March 1, 2028, and March 1, 2029. Following this award, Okun beneficially owns 42,669 shares of Hanover Bancorp common stock in direct ownership.

Insider Trade Summary

Grant/Award: 1,592 shares

Grant/Award 1 txn

Insider Okun Philip A

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	1,592	$0.00	$0.00

Holdings After Transaction: Common Stock — 42,669 shares (Direct)

Footnotes (1)

1. F1. Represents a grant of restricted stock subject to forfeiture, vesting over a three year period, with 1/3 vesting on each of March 1, 2027, March 1, 2028, and March 1, 2029.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Hanover Bancorp (HNVR) report for Philip A. Okun?

Hanover Bancorp director Philip A. Okun reported receiving 1,592 shares of common stock as a restricted stock grant. The award was dated February 5, 2026 and was recorded at a price of $0.0000 per share under a Form 4 insider filing.

How many Hanover Bancorp (HNVR) shares does Philip A. Okun own after this grant?

After the reported restricted stock grant, Philip A. Okun beneficially owns 42,669 shares of Hanover Bancorp common stock. These shares are held in direct ownership, according to the Form 4, and reflect his total holdings following the February 5, 2026 transaction.

What are the vesting terms of Philip A. Okun’s restricted stock in Hanover Bancorp (HNVR)?

The 1,592-share restricted stock grant to Philip A. Okun vests over three years. One-third of the shares vest on March 1, 2027, another third on March 1, 2028, and the final third on March 1, 2029, subject to forfeiture conditions.

Was the Hanover Bancorp (HNVR) restricted stock grant to Philip A. Okun a purchase or an award?

The transaction reported for Philip A. Okun is an award of restricted stock, not an open-market purchase. It is coded as an acquisition (A) of 1,592 common shares at $0.0000 per share, reflecting a compensation-related equity grant rather than a cash investment.

Is Philip A. Okun a director or officer of Hanover Bancorp (HNVR)?

Philip A. Okun is identified as a director of Hanover Bancorp, Inc. in the Form 4 filing. He is not listed as an officer or 10% owner in this report, and the transaction reflects equity compensation linked to his board service.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/09/2026 - 02:49 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Okun Philip A

(Last) (First) (Middle)

C/O HANOVER BANCORP, INC.

80 EAST JERICHO TURNPIKE

(Street)

MINEOLA NY 11501

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Hanover Bancorp, Inc. /MD [ HNVR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/05/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/05/2026		A		1,592(1)	A	$0.0000	42,669	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents a grant of restricted stock subject to forfeiture, vesting over a three year period, with 1/3 vesting on each of March 1, 2027, March 1, 2028, and March 1, 2029.

	/s/ Philip A. Okun	02/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.